Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Cupid rebounds 6% after sharp fall as upgraded FY27 guidance boosts sentiment
Cupid shares rebounded nearly 6% after a sharp correction in the previous session, as investors turned positive following the company’s upgraded FY27 revenue guidance of Rs 660 crore. Strong Q1 momentum, a robust order book, expanding global opportunities, and growth across healthcare, personal care, and wellness businesses helped revive sentiment toward the stock.
Cupid shares gain 2% as firm raises FY27 guidance, expects Q1 revenue to top Rs 150 crore
Cupid shares gained 2% as the company anticipates a record Q1 FY27 revenue exceeding Rs 150 crore. Buoyed by strong market visibility, Cupid has boosted its FY27 revenue forecast to over Rs 660 crore. This optimistic outlook is fueled by diversified business, expanding global opportunities in healthcare, and growth in its condom and lubricant portfolios. The company is also making strides in its IVD business, signaling robust future potential.
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE - Upstox
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSEUpstox
Healthcare stock Cupid shows resilience against the stock market sell-off
Cupid share price rose 3.4% on May 18 after announcing strong Q4 FY26 results, with a 26% year-over-year income increase. The company plans aggressive growth, targeting ₹600 crore revenue in FY27 and expanding its FMCG distribution and product portfolio.